Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 46 results for "leerink swann llc"

D - Leerink Swann Co-Investment Fund, LLC (0001616541) (Filer)

Document Format Files Seq Description Document Type Size 1 primary_doc.html D 1 primary_doc.xml D 7428 Complete submission text file SEC Filings, 1 week ago

Amicus Therapeutics Stock Rating Upgraded by Leerink Swann (FOLD)

Tweet [embedded content] Amicus Therapeutics (NASDAQ:FOLD) was upgraded by equities researchers at Leerink Swann from a market perform rating to an outperform rating in a research report issued on Tuesday, TheFlyOnTheWall.com reports. The ...
 Mideast Time1 month ago Insider Buying: Amicus Therapeutics major shareholder Purchases 4,000,000 Shares of Stock (FOLD)  American Banking News1 month ago Amicus Therapeutics Stock Price Up 21.9% Following Insider Buying Activity (FOLD)  American Banking News1 month ago

Vertex Pharmaceuticals Given New $125.00 Price Target at Leerink Swann (VRTX)

Equities researchers at Leerink Swann upped their price target on shares of Vertex Pharmaceuticals (NASDAQ:VRTX) Vertex Pharmaceuticals (NASDAQ:VRTX) opened at 93.53 on Wednesday. Vertex Pharmaceuticals has a one year low of $58.06 and a one year ...
 American Banking News2 months ago Vertex Pharmaceuticals PT Raised to $107.00 at Sanford C. Bernstein (VRTX)  American Banking News2 months ago
Mideast Time

Stock Analysts Price Target Changes for August, 8th (ABX, AEM, AGU, AMRS, ANDE, ANET, AR, ASCMA, AUMN, AUY)

Stock Analysts price target changes for Friday, August 8th: Barrick Gold (NYSE:ABX) had its target price lowered by CIBC from $23.00 to $22.00. Agnico Eagle Mines (NYSE:AEM) had its target price boosted by CIBC from $40.00 to $45.00. Agrium ...
 Mideast Time2 weeks ago
American Banking News

NPS Pharmaceuticals Given Hold Rating at Jefferies Group (NPSP)

A number of other firms have also recently commented on NPSP. Analysts at Janney Montgomery Scott initiated coverage on shares of NPS Pharmaceuticals in a research note on Thursday, May 22nd. They set a buy rating and a $37.00 price target on the ...
 American Banking News2 weeks ago

TRANSCEPT PHARMACEUTICALS INC - 10-Q - Management's Discussion and Analysis of Financial Condition and Results of Operations

Forward-looking statements involve risks and uncertainties and actual Transcept results and the timing of events may differ significantly from those results discussed in the forward-looking statements. Examples of such forward-looking statements ...
 TMC Net3 weeks ago

Puma Biotech Jumps on Positive Breast Cancer Drug Results

Puma Biotechnology Inc. (PBYI) soared after the company reported yesterday that its experimental drug blocked the return of breast cancer in women with a type of early-stage disease. Puma shares almost quadrupled to $231.17 at 2:21 p.m. in New ...
 Bloomberg1 month ago Puma Biotech Soars on Positive Breast Cancer Drug Results  BusinessWeek1 month ago Puma Biotech Quadruples After Positive Breast Cancer Drug Trial  Washington Post1 month ago

CutisPharma Inc. Appoints MSPH as President

/PRNewswire/ --CutisPharma announced today that it has appointed Neal Muni , MD, MSPH as President and member of the Board of Directors.Dr. Muni will assume responsibility for overseeing the company's commercial operations and guiding development ...
 BioSpace1 month ago CutisPharma Appoints Neal Muni, MD, MSPH as President  OSIX News1 month ago
[x]  
Daily Finance

Will Edwards Lifesciences Stock Slip in the Second Half of 2014?

Edwards Lifesciences 's stock has endured quite the roller coaster over the past two years. In that time, shares of Edwards have fallen by more than 13% as concerns over the company's sales of its Sapien heart valves have swirled. But 2014 has ...
 Daily Finance1 month ago

Gilead Sciences: Cause For Concern?

Summary Gilead has launched the most successful drug in history and is undervalued by typical fundamental metrics. GILD bears cite two main reasons why the stock is overpriced. Is Sovaldi pricing a concern? Is Gilead a "one trick pony"? ...
 Seeking Alpha1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less